AU2001268627A1 - Compositions and methods for generating expression vectors through site-specificrecombination - Google Patents

Compositions and methods for generating expression vectors through site-specificrecombination

Info

Publication number
AU2001268627A1
AU2001268627A1 AU2001268627A AU6862701A AU2001268627A1 AU 2001268627 A1 AU2001268627 A1 AU 2001268627A1 AU 2001268627 A AU2001268627 A AU 2001268627A AU 6862701 A AU6862701 A AU 6862701A AU 2001268627 A1 AU2001268627 A1 AU 2001268627A1
Authority
AU
Australia
Prior art keywords
specificrecombination
compositions
site
methods
expression vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268627A
Inventor
Robin Clark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Protemation Inc
Original Assignee
Protemation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protemation Inc filed Critical Protemation Inc
Publication of AU2001268627A1 publication Critical patent/AU2001268627A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001268627A 2000-06-28 2001-06-20 Compositions and methods for generating expression vectors through site-specificrecombination Abandoned AU2001268627A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/606,323 US6551828B1 (en) 2000-06-28 2000-06-28 Compositions and methods for generating expression vectors through site-specific recombination
US09606323 2000-06-28
PCT/US2001/019770 WO2002000875A2 (en) 2000-06-28 2001-06-20 Compositions and methods for generating expression vectors through site-specific recombination

Publications (1)

Publication Number Publication Date
AU2001268627A1 true AU2001268627A1 (en) 2002-01-08

Family

ID=24427504

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268627A Abandoned AU2001268627A1 (en) 2000-06-28 2001-06-20 Compositions and methods for generating expression vectors through site-specificrecombination

Country Status (3)

Country Link
US (3) US6551828B1 (en)
AU (1) AU2001268627A1 (en)
WO (1) WO2002000875A2 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60042969D1 (en) 1999-03-02 2009-10-29 Life Technologies Corp PREPARATIONS AND METHODS FOR USE IN RECOMBINATORY CLONING OF NUCLEIC ACIDS
WO2002012285A2 (en) * 2000-08-10 2002-02-14 Board Of Regents, The University Of Texas System The tumor suppressor car-1
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
CA2480642C (en) 2002-03-29 2012-10-16 Janet Louise Suttie Lambda integrase mediated recombination in plants
US7164056B2 (en) 2002-05-03 2007-01-16 Pioneer Hi-Bred International, Inc. Gene targeting using replicating DNA molecules
DE10336705A1 (en) * 2003-08-06 2005-03-10 Rina Netzwerk Rna Technologien Process for the preparation of a lysate for cell-free protein biosynthesis
EP1682680B2 (en) * 2003-10-31 2018-03-21 AB Advanced Genetic Analysis Corporation Methods for producing a paired tag from a nucleic acid sequence and methods of use thereof
WO2005054438A2 (en) 2003-12-01 2005-06-16 Invitrogen Corporation Nucleic acid molecules containing recombination sites and methods of using the same
US7935862B2 (en) 2003-12-02 2011-05-03 Syngenta Participations Ag Targeted integration and stacking of DNA through homologous recombination
WO2006099615A2 (en) * 2005-03-16 2006-09-21 The Johns Hopkins University Adenoviral fiber exchange shuttle system
EP1882036B1 (en) * 2005-05-17 2012-02-15 Ozgene Pty Ltd Sequential cloning system
PL204447B1 (en) 2007-07-11 2010-01-29 Linia Zdrowie Niedzielski Czer Ergonomic seat
US9018138B2 (en) * 2007-08-16 2015-04-28 The Johns Hopkins University Compositions and methods for generating and screening adenoviral libraries
US9206431B2 (en) * 2007-09-27 2015-12-08 Academia Sinica Kit for producing recombinant tag-cleavable fusion proteins via at least two different expression vectors allow protein production in two different species host cells
WO2009089384A1 (en) 2008-01-09 2009-07-16 Life Technologies Method of making a paired tag library for nucleic acid sequencing
US9540637B2 (en) 2008-01-09 2017-01-10 Life Technologies Corporation Nucleic acid adaptors and uses thereof
US20100055671A1 (en) * 2008-09-03 2010-03-04 National Tsing Hua University Method for Determining Transduction Efficiency and Virus Dosage of Baculovirus
GB0820631D0 (en) 2008-11-11 2008-12-17 London School Hygiene & Tropical Medicine Vectors
CN101979596B (en) * 2010-02-03 2013-03-06 中国农业大学 Method for constructing recombinant expression vector simultaneously expressing a plurality of genes
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
WO2013043442A1 (en) * 2011-09-23 2013-03-28 Dharmacon, Inc. The introduction of modular vector elements during production of a lentivirus
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
WO2019037099A1 (en) * 2017-08-25 2019-02-28 Wenning Qin Large scale modification of eukaryotic genome
CN111918960A (en) * 2017-12-05 2020-11-10 比奥普来克斯有限公司 Methods and compositions for preventing microbial infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040724A1 (en) 1995-06-07 1996-12-19 Life Technologies, Inc. Recombinational cloning using engineered recombination sites
US5861279A (en) * 1996-01-17 1999-01-19 Schering Corporation Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin 5 antagonists
US5928914A (en) 1996-06-14 1999-07-27 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Methods and compositions for transforming cells
US6534314B1 (en) 1996-06-14 2003-03-18 Massachusetts Institute Of Technology Methods and compositions for transforming cells
US5851808A (en) * 1997-02-28 1998-12-22 Baylor College Of Medicine Rapid subcloning using site-specific recombination
IL135776A0 (en) 1997-10-24 2001-05-20 Life Technologies Inc Recombinational cloning using nucleic acids having recombination sites
WO2000012687A1 (en) * 1998-08-28 2000-03-09 Invitrogen Corporation System for the rapid manipulation of nucleic acid sequences
AU1721600A (en) 1998-11-13 2000-06-05 Life Technologies, Inc. Compositions and methods for recombinational cloning of nucleic acid molecules
DE60042969D1 (en) 1999-03-02 2009-10-29 Life Technologies Corp PREPARATIONS AND METHODS FOR USE IN RECOMBINATORY CLONING OF NUCLEIC ACIDS
US6410317B1 (en) 1999-07-14 2002-06-25 Clontech Laboratories, Inc. Recombinase-based methods for producing expression vectors and compositions for use in practicing the same
WO2001031039A1 (en) 1999-10-25 2001-05-03 Invitrogen Corporation Methods of manipulating and sequencing nucleic acid molecules using transposition and recombination

Also Published As

Publication number Publication date
WO2002000875A3 (en) 2002-05-02
US20060019291A1 (en) 2006-01-26
US20040005591A1 (en) 2004-01-08
US6953689B2 (en) 2005-10-11
WO2002000875A2 (en) 2002-01-03
US6551828B1 (en) 2003-04-22

Similar Documents

Publication Publication Date Title
AU2001268627A1 (en) Compositions and methods for generating expression vectors through site-specificrecombination
AU2001282877A1 (en) Cosmetic compositions
AU2002230642A1 (en) Proton generating catheters and methods for their use
AU2778801A (en) Antisense compositions and methods
WO2002028523A8 (en) Apparatuses containing multiple force generating elements and uses thereof
AU7025201A (en) Expression vectors
AU2001225497A1 (en) Gas generator
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2001262608A1 (en) Semi-solid one- or two-part compositions
AU2001265919A1 (en) Cosmetic compositions
AU2002236542A1 (en) Generator endwinding cooling enhancement
AU2001249380A1 (en) Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
AU2001289099A1 (en) Hair cleanser
AU2001232563A1 (en) Power generating device
AU2001271031A1 (en) Cosmetic compositions for reducing and method of using the same
AU2001281460A1 (en) Gas generator
AU2002332598A1 (en) Compositions and methods for generating antigen-binding units
AU2001275409A1 (en) Methods and compositions for controlled polypeptide synthesis
AU2001253481A1 (en) Methods and compositions for eleciting an immune response
AU2001244702A1 (en) Gas generator
AU2001256202A1 (en) Cosmetic compositions
AU2000274826A1 (en) Cosmetic compositions
AU2001248738A1 (en) Gas generator
AU2002213398A1 (en) Expression vectors and uses thereof
AU2000274825A1 (en) Cosmetic method